Nifty Pharma trading higher by 2.67%
DSIJ Intelligence / 24 Aug 2017
Nifty Pharma was trading higher at the 8,846 level, up by 2.67% on the NSE at 1211 hours, extending gains to nearly 3% since the morning trading hours on Thursday.
Nifty Pharma was trading higher at the 8,846 level, up by 2.67% on the NSE at 1211 hours, extending gains to nearly 3% since the morning trading hours on Thursday. Cadila Healthcare was the top gainer on the index, trading up by 7.46% at Rs 497 per share. This was in the wake of the news that it has received final approval from the USFDA for Candesartan Cilexetil Tablets. The drug is used to treat high blood pressure in adults.
Divi’s Laboratories was trading higher by 3.99% at Rs 663 per share. Lupin was also trading higher by 3.42% at Rs 988 per share and Glenmark was trading up by 3.02% at Rs 617 per share. Among others, Sun Pharma also shot up by 2.94% at Rs 483 per share, Aurobindo Pharma was trading higher by 2.91% at Rs 718, Cipla was up by 1.18% at Rs 565, and Piramal Enterprises was by 1.94% at Rs 2,676 per share.
Dr. Reddy’s was trading up by 1.74% at Rs 2,066 per share. GlaxoSmithKline Pharmaceuticals was trading up by 0.27% at Rs 2,397 per share. Meanwhile, the benchmark index Nifty was trading up by 5 points at 9,857 and Sensex was trading higher by 36 points at 31,604.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.